• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Amines/Sulfonamides

Recent Advances in the Application of 3-Bromo-4-methylaniline (CAS: 7745-91-7) in Chemical Biology and Pharmaceutical Research

3-Bromo-4-methylaniline (CAS: 7745-91-7) is an important intermediate in the synthesis of various pharmaceuticals and agrochemicals. Recent studies have highlighted its versatile applications in medicinal chemistry, particularly in the development of novel therapeutic agents. This research briefing provides an overview of the latest advancements involving this compound, focusing on its synthetic utility, biological activity, and potential industrial applications.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of 3-Bromo-4-methylaniline as a key building block in the synthesis of potent kinase inhibitors. The researchers utilized its bromo substituent for efficient palladium-catalyzed cross-coupling reactions, enabling rapid diversification of the molecular scaffold. This approach led to the discovery of several compounds showing promising activity against cancer-associated protein kinases, with IC50 values in the low nanomolar range.

In the field of antimicrobial research, a team from the University of Cambridge recently reported (Nature Communications, 2024) on the development of novel antibacterial agents derived from 3-Bromo-4-methylaniline. The compound's structure was modified to create a series of analogues that exhibited significant activity against multidrug-resistant Gram-positive bacteria, including MRSA strains. Mechanistic studies revealed that these derivatives interfere with bacterial cell wall biosynthesis, representing a potentially new class of antibiotics.

From a synthetic chemistry perspective, advances in continuous flow technology have improved the production processes for 3-Bromo-4-methylaniline. A 2024 paper in Organic Process Research & Development described an optimized, scalable synthesis route that reduces hazardous waste generation by 40% compared to traditional batch methods. This development is particularly important given the increasing industrial demand for this intermediate in pharmaceutical manufacturing.

The compound has also found applications in materials science. Recent work published in Advanced Materials (2024) demonstrated its utility as a precursor for organic semiconductors. When incorporated into conjugated polymers, 3-Bromo-4-methylaniline-derived monomers contributed to enhanced charge transport properties, opening new possibilities for flexible electronic devices.

Looking forward, the unique chemical properties of 3-Bromo-4-methylaniline continue to inspire innovative applications across multiple disciplines. Current research directions include its potential use in PROTAC (proteolysis targeting chimera) technology for targeted protein degradation, as well as investigations into its metabolic fate and toxicity profile to support safer pharmaceutical development. The compound's versatility ensures it will remain a valuable tool in chemical biology and drug discovery efforts for years to come.

• 55289-36-6(3-Bromo-2-methylaniline)
• 6933-10-4(4-Bromo-3-methylaniline)
• 202925-03-9(4-Bromo-3-methylaniline hydrochloride)
• 67365-47-3(3,5-Dibromo-2-methylaniline)
• 82842-52-2(3-Bromo-2,4,6-trimethylaniline)
• 13194-73-5(3,5-Dibromo-4-methylaniline)
• 59557-90-3(4-Bromo-3,5-dimethylaniline)
• 52121-36-5(3-Bromo-4-ethylaniline)
• 69383-60-4(5-Bromo-2,4-dimethylaniline)
• 16822-92-7(3-Bromo-2-methylaniline hydrochloride)